References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Plowmanetal(1994)Preclinicalantitumoractivityoftemozolomideinmice:efficacyagainsthumanbraintumorxenograftsandsynergismwith1,3-bis(2-chloroethyl)-1-nitrosourea.CancerRes.543793PMID:8033099
Clarketal(1995)Antitumorimidazotetraazines.32.Synthesisofnovelimidazotetrazinonesandrelatedbicyclicheterocyclestoprobethemodeofactionoftheantitumordrugtemozolomide.J.Med.Chem.381493PMID:7739008
Bodelletal(2003)FormationofDNAadductsandinductionoflacImutationsinbigbluerat-2cellstreatedwithtemozolomide:implicationsforthetreatmentoflow-gradeadultandpediatrictumors.CancerEpidemiol.BioMarkersPrevent.12545PMID:
Kanzawaetal(2004)Roleofautophagyintemozolomide-inducedcytotoxicityformalignantgliomacells.CellDeathDiffer.11448PMID:14713959
Keywords:Temozolomide,supplier,DNA-methylating,antitumor,agent,Apoptosis,Inducer,NSC362856,CCRG81045,chemotherapeutics,NSC,362856,CCRG,81045,Apoptosis,Inducers,Autophagy,Apoptosis,Inducers,TocrisBioscience